缬草根水提物的安全性评价:遗传毒性、急性、亚慢性和致畸毒性
本研究评价缬草根水提物(AEVR)的遗传毒性、急性、90天亚慢性及致畸毒性;遗传毒性试验均为阴性,小鼠急性经口LD50>96 g/kg,大鼠亚慢性与致畸NOAEL均不低于14 g/kg,提示AEVR在受试剂量下未显示明显毒性。
要点
- AEVR在细菌回复突变、微核及染色体畸变试验中未显示遗传毒性。
- 小鼠急性经口LD50>96 g/kg,未见死亡或异常行为。
- 大鼠90天亚慢性及致畸试验NOAEL均不低于14 g/kg。
核心结论
- AEVR在体内外试验中未显示遗传毒性。
- 小鼠急性经口LD50大于96 g/kg体重。
- 亚慢性与致畸试验NOAEL不低于14 g/kg体重。
研究设计与样本
- 遗传毒性采用细菌回复突变、小鼠红细胞微核及体外哺乳动物细胞染色体畸变试验。
- 急性毒性:昆明小鼠灌胃96 g/kg体重,观察14天。
- 亚慢性毒性:SD大鼠经口给予0、3.5、7、14 g/kg体重,持续90天。
- 致畸试验:妊娠SD大鼠经口给予0、3.5、7、14 g/kg体重。
主要发现
- 遗传毒性三项试验结果均为阴性。
- 急性毒性试验中96 g/kg剂量下雌雄小鼠均无死亡或异常行为。
- 亚慢性试验各剂量组临床观察、体重、脏器重量、血液学、血清生化及尿液分析未见剂量相关效应。
- 致畸试验中胚胎形成、孕鼠体重及胎鼠外观、骨骼和内脏检查未见显著毒理学改变。
关键数值与推荐
- 小鼠急性经口LD50>96 g/kg体重(雌雄)。
- 大鼠亚慢性与致畸试验NOAEL≥14 g/kg体重。
临床怎么用
- 为缬草作为新资源食品的剂量安全性提供参考。
- 提示在受试剂量范围内AEVR未显示遗传毒性、亚慢性毒性和致畸性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Valeriana officinalis L., commonly known as "valerian", is a traditional herbal medicine distributed in the north temperate zones of America, Europe and Asia. In traditional Chinese medicine, valerian and its roots were used for the treatment of restlessness of the heart and mind, palpitation and insomnia caused by internal depression of emotions and moods. However, safety evaluation of valerian remains deeply unclear. AIM OF THE STUDY: This study aimed to evaluate the genotoxicity, 14-days acute oral toxicity test, 90-day subchronic oral toxicity test and teratogenicity test of aqueous extract of valerian root (AEVR). MATERIALS AND METHODS: The genotoxicity of AEVR was evaluated with bacterial reverse mutation, mouse erythrocyte micronucleus test and in vitro mammalian cell chromosome aberration test. In the 14-days acute toxicity study, Kunming mice were administered at a dosage of 96 g/kg body weigh by gavage. In the 90-day subchronic toxicity study, Sprague-Dawley rats received oral doses of 0, 3.5, 7 and 14 g/kg body weight of AEVR. In the teratogenicity study, pregnant Sprague-Dawley rats received a dose of 0, 3.5, 7 and 14 g/kg body weight of AEVR. RESULTS: AEVR did not show any genotoxicity based on the bacterial reverse mutation, mouse erythrocyte micronucleus test and in vitro mammalian cell chromosome aberration test. In the acute toxicity study, AEVR at a dose of 96 g/kg body weight did not cause death or abnormal behavior in male or female mice. In the subchronic toxicity study, at the doses of 0, 3.5, 7, 14 g/kg body weight, no dose-related effects on clinical observation, body weight, organ weight, hematology, serum biochemistry and urinalysis of AEVR were detected in male or female rats. Teratogenicity test shown that there were no significant toxicologically changes in embryonic formation, body weight of pregnant rats, external, skeletal and visceral examination observed in pregnant and fetal rats at the dosage of 0, 3.5, 7, 14 g/kg body weight. CONCLUSION: In vivo or in vitro assays demonstrated that AEVR does not exhibit genotoxicity. The LD50 of AEVR was greater than 96 g/kg body weight in both sex of mice according to acute oral toxicity study. Subchronic toxicity and teratogenicity tests showed that the no observed adverse effect level (NOAEL) of AEVR was no less than 14 g/kg body weight. This study established a non-toxic dose of AEVR, providing a foundation for the use of valerian as a new resource food in some countries and regions.
引用
- Bao H, Pan X, Tao Q, et al. Safety evaluation of aqueous extract from Valeriana officinalis L. roots: Genotoxicity, acute, subchronic and teratology toxicity. J Ethnopharmacol. 2024. PMID: 39128798. doi:10.1016/j.jep.2024.118687
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。